LRP4 and myasthenia gravis: Within the dSnMG group, 2–27% of patients have Abs direct to the low-density lipoprotein receptor-related protein 4 (LRP4), which plays a role in initiating the AChR cluster, defining them as triple seronegative MG (tSNMG) [7,8].